The goal of the Sealy Institute for Drug Discovery is to translate cutting-edge scientific discoveries into tangible therapeutic solutions.
Working with a dedicated team of scientists, clinicians, drug developers, and industry partners, we strive to develop innovative approaches to diagnose, treat, and prevent kidney disease, neurodegeneration, cancer, aging, and infectious diseases. We work across all classes of drugs, including small molecules, biologics, and nucleotide-based therapeutics, to address the unmet needs of our patients.
The institute is funded by a generous gift from the Sealy & Smith Foundation, underscoring its commitment to advancing the frontiers of biotechnology and medicine in an academic setting, with the ultimate goal of improving patient outcomes.
We want to hear from you, UTMB! Tell us your latest ideas. We will help you move your science toward novel therapies. We also seek collaborations with industry, government, and philanthropic organizations to improve medicine and extend human lives.